Phospholipid based powders for drug delivery applications are disclosed. The powders comprise a polyvalent cation in an amount effective to increase the gel-to-liquid crystal transition temperature of the particle compared to particles without the polyvalent cation. The powders are hollow and porous and are preferably administered via inhalation.

 
Web www.patentalert.com

< Composition for treatment of articular cartilage damage

> Pharmaceutical composition for suppression of apoptosis and method for delivering the same

~ 00499